US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

56.210
-4.270-7.06%

Close Jul 18 16:00 ET

56.810
+0.600+1.07%

Post 19:21 ET

4.77BMarket Cap-20818P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

1,147.32%109.75M

47.48%-260.38M

15.23%-96.07M

62.12%-39.86M

6.14%-133.25M

106.51%8.8M

-191.98%-495.74M

-31.72%-113.33M

-29.37%-105.22M

-117.59%-141.96M

Net income from continuing operations

-119.71%-116.59M

76.37%-153.61M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.07M

-272.16%-650.18M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

Depreciation and amortization

-4.32%4.83M

-17.93%19.84M

-16.18%4.9M

-1.85%4.93M

-31.75%4.96M

-16.36%5.05M

34.64%24.17M

-6.63%5.85M

-5.75%5.02M

98.99%7.27M

Other non cash items

-765.33%-8.39M

-212.63%-14.05M

-2,276.26%-4.77M

-299.96%-5.16M

-188.21%-3.15M

-115.89%-969K

-11.62%12.47M

-95.33%219K

-48.43%2.58M

51.81%3.57M

Change In working capital

470.33%210.49M

-1,075.49%-193.59M

-545.02%-203.97M

41.34%52.56M

-1,066.16%-79.08M

505.53%36.91M

-26.11%19.85M

-271.01%-31.62M

299.96%37.19M

-39.10%8.19M

-Change in receivables

--200M

-65,673.77%-200M

-408,263.27%-200M

411,664.71%70M

-91,009.09%-70M

--0

289.44%305K

132.03%49K

950.00%17K

--77K

-Change in prepaid assets

-75.51%2.95M

1,353.00%23.22M

218.05%6.45M

-83.76%817K

251.69%3.91M

161.11%12.04M

111.49%1.6M

-212.36%-5.46M

154.06%5.03M

41.41%-2.58M

-Change in payables and accrued expense

-62.55%9.44M

-492.08%-20.25M

70.44%-9.19M

-188.32%-24.69M

-216.72%-11.58M

1,660.27%25.21M

-86.23%5.16M

-236.50%-31.1M

2,040.74%27.96M

-48.33%9.92M

-Change in other current liabilities

-154.12%-432K

107.23%110K

7.80%705K

89.29%-110K

68.31%-315K

-10.39%-170K

71.33%-1.52M

-44.48%654K

-67.54%-1.03M

52.76%-994K

-Change in other working capital

-730.51%-1.47M

-76.69%3.33M

-145.76%-1.94M

25.68%6.55M

-162.43%-1.1M

-105.72%-177K

63.92%14.3M

141.61%4.24M

-70.91%5.21M

135.25%1.76M

Cash from discontinued investing activities

Operating cash flow

1,147.32%109.75M

47.48%-260.38M

15.23%-96.07M

62.12%-39.86M

6.14%-133.25M

106.51%8.8M

-191.98%-495.74M

-31.72%-113.33M

-29.37%-105.22M

-117.59%-141.96M

Investing cash flow

Cash flow from continuing investing activities

-183.00%-97.8M

244.84%374.65M

53.60%-81.45M

38.74%121.35M

486.87%216.92M

202.89%117.83M

75.02%-258.66M

-1,913.91%-175.53M

115.48%87.46M

80.90%-56.07M

Net PPE purchase and sale

76.43%-721K

74.53%-9.47M

88.08%-738K

64.80%-2.12M

63.08%-3.56M

80.07%-3.06M

54.49%-37.19M

32.58%-6.19M

83.76%-6.02M

66.15%-9.63M

Net intangibles purchase and sale

----

---2.5M

--0

---1M

----

--0

----

Net investment purchase and sale

-180.30%-97.08M

274.57%386.62M

52.34%-80.72M

33.15%124.47M

577.97%221.98M

221.91%120.89M

76.78%-221.47M

-36,361.46%-169.34M

117.70%93.48M

82.49%-46.44M

Cash from discontinued investing activities

Investing cash flow

-183.00%-97.8M

244.84%374.65M

53.60%-81.45M

38.74%121.35M

486.87%216.92M

202.89%117.83M

75.02%-258.66M

-1,913.91%-175.53M

115.48%87.46M

80.90%-56.07M

Financing cash flow

Cash flow from continuing financing activities

5,561.25%305.93M

62.38%62.66M

1,471.39%38.94M

-89.70%1.56M

61.93%16.77M

-49.25%5.4M

-84.62%38.59M

-60.66%2.48M

47.98%15.11M

22.62%10.35M

Net common stock issuance

--280.75M

3,273.30%32.72M

--32.72M

----

--0

-99.55%970K

--0

----

Proceeds from stock option exercised by employees

366.12%25.19M

-20.41%29.94M

150.93%6.22M

-89.00%1.56M

61.93%16.77M

-49.25%5.4M

-0.15%37.62M

-60.66%2.48M

38.48%14.14M

5.99%10.35M

Cash from discontinued financing activities

Financing cash flow

5,561.25%305.93M

62.38%62.66M

1,471.39%38.94M

-89.70%1.56M

61.93%16.77M

-49.25%5.4M

-84.62%38.59M

-60.66%2.48M

47.98%15.11M

22.62%10.35M

Net cash flow

Beginning cash position

79.00%401.07M

-76.16%224.06M

5.74%539.6M

-11.01%456.6M

-49.18%356.12M

-76.16%224.06M

-20.71%939.94M

-50.38%510.33M

-69.18%513.07M

-38.68%700.81M

Current changes in cash

140.76%317.89M

124.72%176.94M

51.61%-138.59M

3,243.38%83.05M

153.52%100.44M

155.22%132.03M

-191.55%-715.8M

-223.76%-286.38M

99.58%-2.64M

-135.97%-187.68M

Effect of exchange rate changes

-134.38%-11K

191.25%73K

-46.96%61K

52.00%-48K

141.18%28K

218.52%32K

-627.27%-80K

3,733.33%115K

-316.67%-100K

-1,460.00%-68K

End cash Position

101.88%718.94M

79.00%401.07M

5.74%539.6M

-11.01%456.6M

-49.18%356.12M

-76.16%224.06M

-50.38%510.33M

-69.18%513.07M

Free cash flow

1,799.49%109.03M

48.90%-272.35M

19.00%-96.81M

61.37%-42.97M

8.76%-138.3M

103.81%5.74M

-216.55%-532.93M

-25.52%-119.52M

6.03%-111.24M

-119.47%-151.59M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	1,147.32%109.75M	47.48%-260.38M	15.23%-96.07M	62.12%-39.86M	6.14%-133.25M	106.51%8.8M	-191.98%-495.74M	-31.72%-113.33M	-29.37%-105.22M	-117.59%-141.96M
Net income from continuing operations	-119.71%-116.59M	76.37%-153.61M	180.80%89.35M	35.75%-112.15M	58.17%-77.74M	70.39%-53.07M	-272.16%-650.18M	21.72%-110.58M	-37.27%-174.55M	-124.48%-185.83M
Depreciation and amortization	-4.32%4.83M	-17.93%19.84M	-16.18%4.9M	-1.85%4.93M	-31.75%4.96M	-16.36%5.05M	34.64%24.17M	-6.63%5.85M	-5.75%5.02M	98.99%7.27M
Other non cash items	-765.33%-8.39M	-212.63%-14.05M	-2,276.26%-4.77M	-299.96%-5.16M	-188.21%-3.15M	-115.89%-969K	-11.62%12.47M	-95.33%219K	-48.43%2.58M	51.81%3.57M
Change In working capital	470.33%210.49M	-1,075.49%-193.59M	-545.02%-203.97M	41.34%52.56M	-1,066.16%-79.08M	505.53%36.91M	-26.11%19.85M	-271.01%-31.62M	299.96%37.19M	-39.10%8.19M
-Change in receivables	--200M	-65,673.77%-200M	-408,263.27%-200M	411,664.71%70M	-91,009.09%-70M	--0	289.44%305K	132.03%49K	950.00%17K	--77K
-Change in prepaid assets	-75.51%2.95M	1,353.00%23.22M	218.05%6.45M	-83.76%817K	251.69%3.91M	161.11%12.04M	111.49%1.6M	-212.36%-5.46M	154.06%5.03M	41.41%-2.58M
-Change in payables and accrued expense	-62.55%9.44M	-492.08%-20.25M	70.44%-9.19M	-188.32%-24.69M	-216.72%-11.58M	1,660.27%25.21M	-86.23%5.16M	-236.50%-31.1M	2,040.74%27.96M	-48.33%9.92M
-Change in other current liabilities	-154.12%-432K	107.23%110K	7.80%705K	89.29%-110K	68.31%-315K	-10.39%-170K	71.33%-1.52M	-44.48%654K	-67.54%-1.03M	52.76%-994K
-Change in other working capital	-730.51%-1.47M	-76.69%3.33M	-145.76%-1.94M	25.68%6.55M	-162.43%-1.1M	-105.72%-177K	63.92%14.3M	141.61%4.24M	-70.91%5.21M	135.25%1.76M
Cash from discontinued investing activities
Operating cash flow	1,147.32%109.75M	47.48%-260.38M	15.23%-96.07M	62.12%-39.86M	6.14%-133.25M	106.51%8.8M	-191.98%-495.74M	-31.72%-113.33M	-29.37%-105.22M	-117.59%-141.96M
Investing cash flow
Cash flow from continuing investing activities	-183.00%-97.8M	244.84%374.65M	53.60%-81.45M	38.74%121.35M	486.87%216.92M	202.89%117.83M	75.02%-258.66M	-1,913.91%-175.53M	115.48%87.46M	80.90%-56.07M
Net PPE purchase and sale	76.43%-721K	74.53%-9.47M	88.08%-738K	64.80%-2.12M	63.08%-3.56M	80.07%-3.06M	54.49%-37.19M	32.58%-6.19M	83.76%-6.02M	66.15%-9.63M
Net intangibles purchase and sale	----	---2.5M	--0	---1M	----	----	--0	--0	--0	----
Net investment purchase and sale	-180.30%-97.08M	274.57%386.62M	52.34%-80.72M	33.15%124.47M	577.97%221.98M	221.91%120.89M	76.78%-221.47M	-36,361.46%-169.34M	117.70%93.48M	82.49%-46.44M
Cash from discontinued investing activities
Investing cash flow	-183.00%-97.8M	244.84%374.65M	53.60%-81.45M	38.74%121.35M	486.87%216.92M	202.89%117.83M	75.02%-258.66M	-1,913.91%-175.53M	115.48%87.46M	80.90%-56.07M
Financing cash flow
Cash flow from continuing financing activities	5,561.25%305.93M	62.38%62.66M	1,471.39%38.94M	-89.70%1.56M	61.93%16.77M	-49.25%5.4M	-84.62%38.59M	-60.66%2.48M	47.98%15.11M	22.62%10.35M
Net common stock issuance	--280.75M	3,273.30%32.72M	--32.72M	----	----	--0	-99.55%970K	--0	----	----
Proceeds from stock option exercised by employees	366.12%25.19M	-20.41%29.94M	150.93%6.22M	-89.00%1.56M	61.93%16.77M	-49.25%5.4M	-0.15%37.62M	-60.66%2.48M	38.48%14.14M	5.99%10.35M
Cash from discontinued financing activities
Financing cash flow	5,561.25%305.93M	62.38%62.66M	1,471.39%38.94M	-89.70%1.56M	61.93%16.77M	-49.25%5.4M	-84.62%38.59M	-60.66%2.48M	47.98%15.11M	22.62%10.35M
Net cash flow
Beginning cash position	79.00%401.07M	-76.16%224.06M	5.74%539.6M	-11.01%456.6M	-49.18%356.12M	-76.16%224.06M	-20.71%939.94M	-50.38%510.33M	-69.18%513.07M	-38.68%700.81M
Current changes in cash	140.76%317.89M	124.72%176.94M	51.61%-138.59M	3,243.38%83.05M	153.52%100.44M	155.22%132.03M	-191.55%-715.8M	-223.76%-286.38M	99.58%-2.64M	-135.97%-187.68M
Effect of exchange rate changes	-134.38%-11K	191.25%73K	-46.96%61K	52.00%-48K	141.18%28K	218.52%32K	-627.27%-80K	3,733.33%115K	-316.67%-100K	-1,460.00%-68K
End cash Position	101.88%718.94M	79.00%401.07M	79.00%401.07M	5.74%539.6M	-11.01%456.6M	-49.18%356.12M	-76.16%224.06M	-76.16%224.06M	-50.38%510.33M	-69.18%513.07M
Free cash flow	1,799.49%109.03M	48.90%-272.35M	19.00%-96.81M	61.37%-42.97M	8.76%-138.3M	103.81%5.74M	-216.55%-532.93M	-25.52%-119.52M	6.03%-111.24M	-119.47%-151.59M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall